Atreca (NASDAQ:BCEL) reported quarterly losses of $(0.72) per share. This is unchanged from the same period last year.
‘DEA Wants Nearly 1 Million Grams Of Delta-9 THC Manufactured For Research Next Year In Latest Schedule I Quota Hike’ – MarijuanaMoment
https://www.marijuanamoment.net/dea-wants-nearly-1-million-grams-of-delta-9-thc-manufactured-for-research-next-year-in-latest-schedule-i-quota-hike/The Drug Enforcement Administration (DEA) is looking to substantially
